STEREOTACTIC BODY VERSUS CONVENTIONAL FRACTIONATION EXTERNAL BEAM RADIOTHERAPY (EBRT) BOOST FOR HIGH-RISK PROSTATE CANCER (HR-PC); EARLY RESULTS OF PBS: A PHASE II RANDOMIZED TRIAL (NCT03380806)

被引：0
|
作者：
Gouveia, Andre [1 ]
Mesci, Aruz [2 ]
Isfahanian, Naghmeh [1 ]
Dayes, Ian [1 ]
Schnarr, Kara Lynne [1 ]
Quan, Kimmen [1 ]
Maharaj, Lindsay [3 ]
Cuthbert, David [4 ]
Hallock, Abhiram [4 ]
Douvi, Georgia [1 ]
Lukka, Himu [1 ]
Goldberg, Mira [1 ]
Wright, Jim [1 ]
Swaminath, Anand [1 ]
Chow, Tom [5 ]
Diamond, Kevin [4 ]
Ewusie, Joycelyne [6 ]
Hajdok, George [4 ]
Tsakiridis, Theodoros [1 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Hamilton Hlth Sci, Hamilton, ON, Canada
[4] Walker Family Canc Ctr, St Catharines, ON, Canada
[5] Juravinski Canc Ctr, Hamilton, ON, Canada
[6] St Josephs Hlth Care, Hamilton, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 198卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
23
引用
收藏
页码：S13 / S14
页数：2
相关论文
共 34 条
  • [1] Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for Unfavorable Intermediate and High-Risk Prostate Cancer; Early Results of PBS: A Phase II Randomized Trial (NCT03380806)
    Gouveia, A. G.
    Mesci, A.
    Isfahanian, N.
    Dayes, I.
    Quan, K.
    Goldberg, M.
    Schnarr, K. L.
    Lukka, H.
    Cuthbert, D.
    Hallock, A.
    Douvi, G.
    Wright, J.
    Swaminath, A.
    Chow, T.
    Diamond, K.
    Hajdok, G.
    Maharaj, L.
    Ewusive, J.
    Tsakiridis, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S126 - S127
  • [2] A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806)
    Isfahanian, Naghmeh
    Lukka, Himanshu
    Dayes, Ian
    Quan, Kimmen
    Schnarr, Kara Lynne
    Douvi, Georgia
    Goldberg, Mira
    Wright, Jim
    Swaminath, Anand
    Chow, Tom
    Diamond, Kevin
    Cutz, Jean Claude
    Kavsak, Peter
    Thabane, Lehana
    Tsakiridis, Theodoros
    CLINICAL GENITOURINARY CANCER, 2020, 18 (04) : E410 - E415
  • [3] A RANDOMIZED PHASE II TRIAL OF PROSTATE BOOST IRRADIATION WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN HIGH-RISK PROSTATE CANCER. THE PBS TRIAL
    Douvi, Georgia
    Isfahanian, Naghmeh
    Lukka, Himanshu
    IanDayes
    Quan, Kimmen
    Schnarr, Kara Lynne
    Goldberg, Mira
    Wright, Jim
    Hallock, Abhirami
    Ishkanian, Adrian
    Cuthbert, David
    Swaminath, Anand
    Chow, Tom
    Diamond, Kevin
    Cutz, Jean-Claude
    Kavsak, Peter
    Thabane, Lehana
    Tsakiridis, Theodoros
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S87 - S88
  • [4] Stereotactic body radiotherapy as a boost after external beam radiotherapy for high-risk prostate cancer patients
    Turna, Menekse
    Akboru, Halil
    Ermis, Ekin
    Oskeroglu, Sedenay
    Dincer, Selvi
    Altin, Suleyman
    INDIAN JOURNAL OF CANCER, 2021, 58 (04) : 518 - 524
  • [5] PROSTATE SBRT BOOST RADIOTHERAPY (PBS TRIAL): A RANDOMIZED PHASE II TRIAL OF SBRT VERSUS CONVENTIONALLY-FRACTIONATED RADIOTHERAPY BOOST FOLLOWING PELVIC RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER
    Mesci, Aruz
    Isfahanian, Naghmeh
    Douvi, Georgia
    Gouran-Savadkoohi, Mohammad
    Dayes, Ian
    Lukka, Himanshu
    Quan, Kimmen
    Schnarr, Kara
    Goldberg, Mira
    Hallock, Abhirami
    Chow, Tom
    Diamond, Kevin
    Jakubovic, Raphael
    Thabane, Lahane
    Tsakiridis, Theodoros
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S64 - S64
  • [6] Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
    Yeon Joo Kim
    Hanjong Ahn
    Choung-Soo Kim
    Young Seok Kim
    Radiation Oncology, 15
  • [7] Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
    Kim, Yeon Joo
    Ahn, Hanjong
    Kim, Choung-Soo
    Kim, Young Seok
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [8] Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: Preliminary Toxicity Results of a Phase 2 Trial
    Kishan, A. U.
    Fuller, D. B.
    Steinberg, M. L.
    Ramirez, V.
    Ostendorf, E.
    Tsai, S. H.
    Agazaryan, N.
    Ruan, D.
    Cao, M.
    Kupelian, P. A.
    King, C. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E248 - E248
  • [9] Stereotactic body radiotherapy for high-risk prostate cancer (5 treatment days): Toxicity results of a phase II trial.
    Kishan, Amar Upadhyaya
    Fuller, Donald B.
    Steinberg, Michael L.
    Ramirez, Victoria
    Agazaryan, Nzhde
    Ruan, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [10] A PROSPECTIVE PHASE III RANDOMIZED TRIAL OF HYPOFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN PATIENTS WITH HIGH-RISK PROSTATE CANCER
    Arcangeli, Giorgio
    Saracino, Biancamaria
    Gomellini, Sara
    Petrongari, Maria Grazia
    Arcangeli, Stefano
    Sentinelli, Steno
    Marzi, Simona
    Landoni, Valeria
    Fowler, Jack
    Strigari, Lidia
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 11 - 18
1234